There are 2867 resources available
Expanding the armamentarium with IO-TKIs combinations – what can be learnt from RCC for the future of NSCLC?
Presenter: Guillermo Antonio De Velasco Oria
Session: Ipsen - Disrupting the landscape: the Plus One in RCC and NSCLC
Resources:
Webcast
State of the art first-line management of patients with advanced RCC
Presenter: Toni Choueiri
Session: ESMO Colloquium Supported by Eisai Europe Ltd.: Optimising outcomes of patients with advanced renal cancer
Resources:
Webcast
Physician's perspective... Am I fine?
Presenter: Fatima Cardoso
Session: I am FINE: Frustrated * Isolated * Neglected * Emotional
Resources:
Slides
Webcast
The emerging continuum of care in advanced RCC: Second-line and beyond
Presenter: Camillo Guglielmo Porta
Session: ESMO Colloquium Supported by Eisai Europe Ltd.: Optimising outcomes of patients with advanced renal cancer
Resources:
Webcast
The grass is greener: Deciding on the most appropriate initial treatment for patients with mHSPC
Presenter: Heather Payne
Session: Astellas - The maturing treatment landscape of mHSPC
Resources:
Webcast
Immunotherapy, targeted therapy and beyond: navigating options for metastatic disease
Presenter: Martin Reck
Session: F. Hoffmann-La Roche Ltd - Redefining Lung Cancer Together: Now and Next
Resources:
Webcast
Unmet needs in NSCLC: targeting second-line treatment with TKI-IO
Presenter: Luis Paz-Ares
Session: Ipsen - Disrupting the landscape: the Plus One in RCC and NSCLC
Resources:
Webcast
Nurse’s perspective... Am I fine?
Presenter: Lena Sharp
Session: I am FINE: Frustrated * Isolated * Neglected * Emotional
Resources:
Slides
Webcast
Presentation of two clinical vignettes: Optimising dose-intensity and tolerance
Presenter: Cristina Suarez Rodriguez
Session: ESMO Colloquium Supported by Eisai Europe Ltd.: Optimising outcomes of patients with advanced renal cancer
Resources:
Webcast
Q&A
Presenter: Shahrokh F. Shariat
Session: Astellas - The maturing treatment landscape of mHSPC
Resources:
Webcast